Immediate Impact
3 from Science/Nature 59 standout
Citing Papers
Oesophageal cancer
2024 Standout
The effect of higher protein dosing in critically ill patients with high nutritional risk (EFFORT Protein): an international, multicentre, pragmatic, registry-based randomised trial
2023 Standout
Works of Caroline Archer being referenced
Matuzumab plus epirubicin, cisplatin and capecitabine (ECX) compared with epirubicin, cisplatin and capecitabine alone as first-line treatment in patients with advanced oesophago-gastric cancer: a randomised, multicentre open-label phase II study
2010
A double blind, randomised, controlled trial of glutamine supplementation in parenteral nutrition
1999
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Caroline Archer | 243 | 99 | 124 | 156 | 19 | 513 | |
| Diana M. Merino | 197 | 211 | 197 | 129 | 20 | 649 | |
| Xianwen Zhao | 181 | 140 | 177 | 83 | 14 | 570 | |
| Merry Tetef | 255 | 115 | 146 | 112 | 28 | 559 | |
| Bryan M. Gillard | 129 | 107 | 312 | 121 | 25 | 595 | |
| Shunji Miki | 233 | 81 | 188 | 92 | 15 | 647 | |
| D.A.K. Black | 137 | 93 | 125 | 73 | 17 | 536 | |
| Marvin A. Jackson | 83 | 89 | 72 | 223 | 14 | 481 | |
| Martin Y. Heshmat | 123 | 121 | 58 | 352 | 15 | 644 | |
| Young Sun Lee | 132 | 110 | 122 | 361 | 17 | 566 | |
| Bertram Illert | 153 | 138 | 284 | 67 | 30 | 631 |
All Works
Login with ORCID to disown or claim papers
Loading papers...